• Amima Salam Transformation Wellness Clinics
Keywords: rtms, mental health, treatment age, depression, anxiety, OCD, mania


repetitive Transcranial Magnetic Stimulation (rTMS) is a form of brain stimulation therapy which is approved by FDA (USA) and CE (Europe). In rTMS treatment, an instrument called a stimulator supplies electrical energy to a magnetic coil that generates a magnetic field in the brain for a short period of time. rTMS is based on the principle of electromagnetic induction that can either stimulate or inhibit the neuronal activity of specific brain areas as per need. This drug free treatment is helpful in many neurological and psychological disorders such as depression, OCD, migraines, autism, ADHD, epilepsy, Bipolar and sexual disorders. The treatment is so safe that it could be conducted on one year old child to an old age. It is an outpatient procedure which does not require hospitalization or anesthesia and entails no memory loss. After the session, patients require no recovery period and are able to go about their daily activities immediately following treatment. Other than some precautions, it is often ideal for patients, because it has none of the side effects of traditional medications and other treatments. It can be said rtms is a focal, non-invasive and very well-tolerated form of brain stimulation in clinical use which is safe for almost all patients suffering from mental or psychological disturbance.


1. Marcolin MA, Padberg F, editors. Transcranial brain stimulation for treatment of psychiatric disorders. Karger Medical and Scientific Publishers; 2007.
2. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985 May 11;1(8437):1106-7 [cited 27th November 2022]. Available from:
3. Wassermann EM, Lisanby SH [Internet]. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol. 2(8):1367-77 [cited 27th November 2022]. Available from:
4. Clinical TMS Society [Interner]. [cited 27th November 2022] Available from:
5. Noohi S, Amirsalari S [Internet]. History, Studies and Specific Uses of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treating Epilepsy. Iran J Child Neurol. Winter;10(1):1-8. PMID: 27057180; PMCID: PMC4815479 [cited 27th November 2022]. Available from:
6. Jorm AF [Internet]. Mental health literacy: public knowledge and beliefs about mental disorder. Br J Psychiatry. 2000; 177:396–401 [cited 27th November 2022]. Available from:
7. Jorm AF [Internet]. Mental health literacy: empowering the community to take action for better mental health. American Psychologist, 2012. 67(3), 231–243 [cited 27th November 2022]. Available from:
8. FDA news Release [Internet]. FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder [cited 26th November 2022]. Available from:
9. Chen L, Hudaib AR, Hoy KE, Fitzgerald PB [Internet]. Is rTMS effective for anxiety symptoms in major depressive disorder? An efficacy analysis comparing left-sided high-frequency, right-sided low-frequency, and sequential bilateral rTMS protocols. Depress Anxiety. 2019 Aug;36(8):723-731. [cited 29th November 2022] Available from:
10. Cirillo P, Gold AK, Nardi AE, Ornelas AC, Nierenberg AA, Camprodon J, Kinrys G [Internet]. Transcranial magnetic stimulation in anxiety and trauma-related disorders: A systematic review and meta-analysis. Brain Behav. 2019 Jun;9(6):e01284. [cited 29th November 2022] Available from:
11. Grisaru N, Chudakov B. Yaroslavsky Y and Belmaker R H [Internet], Transcranial Magnetic Stimulation in Mania: A Controlled Study. The American Journal of Psychiatry.[cited 29th November 2022]. Available from
12. Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS [Internet]. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul. 2016 May-Jun;9(3):336-346 [cited 25th November 2022]. Available from:
13. Donaldson AE, Gordon MS, Melvin GA, Barton DA, Fitzgerald PB [Internet]. Addressing the needs of adolescents with treatment resistant depressive disorders: a systematic review of rTMS. Brain Stimul. 2014 Jan-Feb;7(1):7-12. [cited: 29th November 2022]. Available from:
14. Connolly KR, Helmer A, Cristancho MA, Cristancho P, O'Reardon JP [Internet]. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. J Clin Psychiatry. 2012 Apr;73(4):e567-73 [cited 27th November 2022]. Available from:
15. Griffiths C, da Silva KM, Leathlean C, Jiang H, Ang CS, Searle R [Internet]. Investigation of physical activity, sleep, and mental health recovery in treatment resistant depression (TRD) patients receiving repetitive transcranial magnetic stimulation (rTMS) treatment. J Affect Disord Rep. 100337 [cited 26th November 2022]. Available from:
16. Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF [Internet]. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010 Oct;3(4):187-99 [cited 25th November 2022]. Available from:
17. Mann SK, Malhi NK [Internet]. Repetitive Transcranial Magnetic Stimulation. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan [cited 27th November 2022]. Available from:
18. Wang X, Mao Z, Ling Z, Yu X [Internet]. Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials. J Neurol. 2020 Mar. 267(3):791-801 [cited 25th November 2022]. Available from:
19. Morrison, A.S., Uusberg, A., Ryan, J. et al [Internet]. Assessing and improving public mental health literacy concerning rTMS. BMC Psychiatry 22, 249 (2022) [cited 25th November 2022]. Available from:
20. Medical Advisory Secretariat [Internet]. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ont Health Technol Assess Ser. 2004;4(7):1-98. Epub 2004 Jun 1 [cited 25th November 2022]. Available from:
21. David Feifel, David L. Dunner, and Daniel Z [Internet]. Roles and Qualifications of TMS Treatment Team Members. The Journal of Clinical Psychiatry [cited 28th November 2022]. Available from:
22. The Health Technology Assessment Unit, University of Calgary [Internet]. Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-resistant Depression [cited 28th November 2022] Available from:
23. Israel. Dr. Lindsay [Internet]. What Are the Side Effects and Risks of TMS Treatments?. [cited 27th November 2022]. Available from:
24. Brainsway [Internet]. Repetitive Transcranial Magnetic Stimulation (rTMS)? [cited 27th November 2022]. Available from:
How to Cite